Comprehensive Bridging Radiotherapy for Limited Pre-CART Non-Hodgkin Lymphoma.

JAMA oncology(2024)

Cited 0|Views9
No score
Abstract
This cohort study examines the role of comprehensive bridging radiotherapy in the setting of chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined